Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Ginkgo Bioworks
DNA
Gross margin
Gross margin at other companies
TEC
Bio-Techne
TECH
65%
-0.8pp
Azenta
AZTA
40%
-1.0pp
Regenxbio
RGNX
59.7%
+1.0pp
Maravai LifeSciences Holdings, Inc.
MRVI
29.3%
-8.0pp
Bio-Rad Laboratories
BIO
51.9%
-1.6pp
Danaher
DHR
58.9%
-0.8pp
Other financials
Income statement
See full
Revenue
$19.5M
-49.1%
Gross profit
$16.4M
-52.0%
Operating income
-$71.4M
+11.9%
Net income
-$82.6M
+9.2%
EPS (diluted)
-$1.42
+27.6%
Balance sheet
See full
Cash & equivalents
$188.7M
-46.9%
Total debt
$410.7M
-5.5%
Total equity
$443.2M
-31.6%
Total assets
$1.0B
-20.1%
Cash flow
See full
Operating cash flow
-$46.7M
+9.4%
CapEx
$1.9M
-74.6%
Free cash flow
-$48.6M
+17.8%
Valuation
See full
Market cap
$625.16M
+24.6%
Enterprise value
$847.19M
+45.9%
P/S
4.4×
+2.2×
Profitability
See full
Operating margin
-210.7%
+7.6pp
Net margin
-215.4%
+8.3pp
FCF margin
-119%
-21.2pp
Returns & leverage
See full
Return on equity
-55.8%
-1.8pp
Debt / equity
0.9×
+0.3×
Current ratio
5.2×
+0.3×